Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation. [electronic resource]

By:

Kobayashi, Miki

Contributor(s):

Kubo, Satoshi
Shiraki, Katsuhisa
Iwata, Masahiro
Hirano, Yasuno
Ohtsu, Yoshiaki
Takahashi, Koichiro
Shimizu, Yasuaki

Producer: 20130422Description: 223-32 p. digitalISSN:

1423-0313

Subject(s):

Animals
Asthma -- blood
Bronchial Hyperreactivity -- drug therapy
Chronic Disease
Eosinophilia -- blood
Female
Fibrinogen -- analysis
Humans
Interleukin-5 -- biosynthesis
Male
Naphthyridines -- therapeutic use
Phosphodiesterase 4 Inhibitors -- therapeutic use
Rats
Rats, Inbred BN
Rats, Inbred F344
Tumor Necrosis Factor-alpha -- biosynthesis

Online resources:

Available from publisher's website

In: Pharmacology vol. 90

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation.

APA

Kobayashi M., Kubo S., Shiraki K., Iwata M., Hirano Y., Ohtsu Y., Takahashi K. & Shimizu Y. (20130422). Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation. : Pharmacology.

Chicago

Kobayashi Miki, Kubo Satoshi, Shiraki Katsuhisa, Iwata Masahiro, Hirano Yasuno, Ohtsu Yoshiaki, Takahashi Koichiro and Shimizu Yasuaki. 20130422. Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation. : Pharmacology.

Harvard

Kobayashi M., Kubo S., Shiraki K., Iwata M., Hirano Y., Ohtsu Y., Takahashi K. and Shimizu Y. (20130422). Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation. : Pharmacology.

MLA

Kobayashi Miki, Kubo Satoshi, Shiraki Katsuhisa, Iwata Masahiro, Hirano Yasuno, Ohtsu Yoshiaki, Takahashi Koichiro and Shimizu Yasuaki. Therapeutic potential of ASP3258, a selective phosphodiesterase 4 inhibitor, on chronic eosinophilic airway inflammation. : Pharmacology. 20130422.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC